Insmed INSM
$141.33 −$3.13 (-2.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $142.81 +1.05%
Open$143.27
Prev close$144.46
Day range$140.99 – $150.00
Volume6.22M
Market cap$31.01B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$524.43M+268.4% YoY
Operating profit-$81.83M+68.7% YoY
Net profit-$100.32M+72.9% YoY
Diluted EPS-$0.46+73.7% YoY
Free cash flow-$42.09M+81.1% YoY
Operating cash flow-$36.46M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin84.4%
Operating margin-41.7%
Net margin-39.9%
Return on equity-72.5%
Return on assets-26.4%
Return on invested capital-39.6%
Current ratio2.86
Liabilities / assets67.4%
Cash & investments$1.15B
Total debt$572.90M
Net cash (debt)$573.73M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $524.43M | $425.49M | $305.96M | $606.42M | $263.84M |
| Total Operating Revenue | $524.43M | $425.49M | $305.96M | $606.42M | $263.84M |
| Cost of Revenue | $78.22M | $67.21M | $47.42M | $122.94M | $44.22M |
| Gross Profit | $446.21M | $358.27M | $258.54M | $483.49M | $219.62M |
| Operating Expense | $528.04M | $459.58M | $458.83M | $1.48B | $469.33M |
| Selling and Admin Expenses | $253.03M | $247.47M | $247.26M | $701.17M | $212.48M |
| -General & Admin Expense | $253.03M | $247.47M | $247.26M | $701.17M | $212.48M |
| Research & Development | $269.96M | $210.03M | $209.49M | $771.09M | $254.91M |
| Depreciation & Amortization & Depletion | $5.05M | $2.08M | $2.08M | $6.00M | $1.94M |
| -Depreciation & Amortization | $5.05M | $2.08M | $2.08M | $6.00M | $1.94M |
| Operating Profit | -$81.83M | -$101.31M | -$200.28M | -$994.78M | -$249.71M |
| Net Non-Operating Interest Income (Expense) | -$20.41M | -$20.27M | -$20.08M | -$83.80M | -$20.60M |
| Non-Operating Interest Expense | $18.93M | $18.84M | $18.70M | $77.58M | $19.22M |
| Total Other Finance Costs | $1.48M | $1.43M | $1.38M | $6.22M | $1.38M |
| Other Income (Expense) | $4.59M | $110.21M | $58.27M | -$193.18M | -$56.63M |
| Gain on Sale of Security | $11.07M | $10.98M | $12.04M | $60.66M | $15.24M |
| Special Income (Charges) | -$7.54M | $99.76M | $46.96M | -$251.99M | -$70.04M |
| -Less:Restructuring and Mergern & Acquisition | $7.54M | -$99.76M | -$46.96M | $251.99M | $70.04M |
| Other Non-Operating Income (Expenses) | $1.06M | -$531,000.00 | -$736,000.00 | -$1.84M | -$1.82M |
| Pretax Profit | -$97.65M | -$11.37M | -$162.10M | -$1.27B | -$326.93M |
| Tax | $2.67M | $1.87M | $1.47M | $5.03M | $1.55M |
| Net Profit | -$100.32M | -$13.24M | -$163.56M | -$1.28B | -$328.49M |
| Profit from Continuing Operations | -$100.32M | -$13.24M | -$163.56M | -$1.28B | -$328.49M |
| Net Income to Parent Company | -$100.32M | -$13.24M | -$163.56M | -$1.28B | -$328.49M |
| Net Income to Common Stockholders | -$100.32M | -$13.24M | -$163.56M | -$1.28B | -$328.49M |
| Basic EPS | -$0.46 | -$0.06 | -$0.76 | -$6.42 | -$1.54 |
| Diluted EPS | -$0.46 | -$0.06 | -$0.76 | -$6.42 | -$1.54 |
| Non-Operating Interest Income | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.23B | $2.10B | $2.08B | $2.26B | $2.26B |
| Total Current Assets | $1.71B | $1.63B | $1.61B | $1.79B | $1.79B |
| Cash and Cash Equivalents & Short-Term Investments | $1.15B | $1.16B | $1.22B | $1.43B | $1.43B |
| -Cash and Cash Equivalents | $396.56M | $544.77M | $582.19M | $510.45M | $510.45M |
| -Short Term Investments | $750.06M | $615.55M | $641.33M | $919.60M | $919.60M |
| Receivables | $259.27M | $215.33M | $178.56M | $140.86M | $140.86M |
| -Accounts Receivable | $259.27M | $215.33M | $178.56M | $140.86M | $140.86M |
| Inventory | $163.95M | $142.38M | $132.91M | $132.07M | $132.07M |
| Other Current Assets | $136.67M | $115.90M | $78.20M | $91.24M | $91.24M |
| Total Non-Current Assets | $519.55M | $468.65M | $462.69M | $470.35M | $470.35M |
| Net PPE | $139.49M | $134.60M | $131.73M | $139.21M | $139.21M |
| -Gross PPE | $209.57M | $201.30M | $195.33M | $199.97M | $199.97M |
| -Accumulated Depreciation | -$70.08M | -$66.70M | -$63.59M | -$60.76M | -$60.76M |
| Goodwill and Other Intangible Assets | $274.55M | $229.60M | $231.68M | $233.76M | $233.76M |
| -Goodwill | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M |
| -Other Intangible Assets | $138.44M | $93.49M | $95.57M | $97.65M | $97.65M |
| Other Non-Current Assets | $105.51M | $104.44M | $99.28M | $97.38M | $97.38M |
| Total Liabilities | $1.50B | $1.35B | $1.37B | $1.53B | $1.53B |
| Total Current Liabilities | $596.58M | $438.74M | $361.01M | $468.87M | $468.87M |
| Payables | $148.62M | $128.94M | $102.64M | $103.46M | $103.46M |
| -Accounts Payable | $84.30M | $74.56M | $73.38M | $79.91M | $79.91M |
| -Other Payable | $64.32M | $54.39M | $29.26M | $23.55M | $23.55M |
| Current Accrued Expenses | $348.51M | $238.41M | $203.93M | $241.09M | $241.09M |
| Short-Term Debt and Capital Lease Obligation | $11.81M | $9.82M | $8.45M | $12.81M | $12.81M |
| -Current Capital Lease Obligation | $11.81M | $9.82M | $8.45M | $12.81M | $12.81M |
| Other Current Liabilities | $10.23M | – | – | – | – |
| Total Non-Current Liabilities | $903.27M | $906.33M | $1.01B | $1.06B | $1.06B |
| Long Term Debt and Capital Lease Obligation | $572.90M | $570.07M | $571.87M | $573.86M | $573.86M |
| -Long Term Debt | $544.86M | $543.51M | $542.22M | $540.96M | $540.96M |
| -Long Term Capital Lease Obligation | $28.04M | $26.55M | $29.66M | $32.89M | $32.89M |
| Other Non-Current Liabilities | $330.37M | $336.26M | $438.13M | $482.85M | $482.85M |
| Total Equity | $726.21M | $757.49M | $704.85M | $738.98M | $738.98M |
| Stockholders' Equity | $726.21M | $757.49M | $704.85M | $738.98M | $738.98M |
| Capital Stock | $2.19M | $2.18M | $2.17M | $2.14M | $2.14M |
| -Common Stock | $2.19M | $2.18M | $2.17M | $2.14M | $2.14M |
| Additional Paid-In Capital | $6.64B | $6.57B | $6.50B | $6.37B | $6.37B |
| Retained Earnings | -$5.91B | -$5.81B | -$5.80B | -$5.64B | -$5.64B |
| Gains/Losses Not Affecting Retained Earnings | -$40,000.00 | -$3.37M | $4,000.00 | $1.46M | $1.46M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$36.46M | -$88.83M | -$222.74M | -$935.01M | -$247.60M |
| Net cash flow from continuing operations | -$36.46M | -$88.83M | -$222.74M | -$935.01M | -$247.60M |
| Net Income from Continuing Operations | -$100.32M | -$13.24M | -$163.56M | -$1.28B | -$328.49M |
| Depreciation & Depletion & Amortization | $8.40M | $5.26M | $5.02M | $16.45M | $5.56M |
| Other Non-Cash Items | $15.60M | -$91.71M | -$39.22M | $291.25M | $84.33M |
| Change in Working Capital | $3.47M | -$24.93M | -$64.21M | -$80.30M | -$37.64M |
| -Change in Receivables | -$43.10M | -$37.16M | -$38.19M | -$88.31M | -$77.30M |
| -Change in Inventory | -$18.00M | -$12.97M | -$1.89M | -$31.52M | -$11.76M |
| -Change in Prepaid Assets | -$20.56M | -$37.64M | $12.59M | -$53.43M | -$26.22M |
| -Change in Payables and Accrued Expense | $87.07M | $68.82M | -$33.88M | $100.07M | $90.35M |
| -Change in Other Current Assets | -$1.16M | -$5.23M | -$2.36M | -$2.12M | -$11.79M |
| -Change in Other Current Liabilities | -$769,000.00 | -$744,000.00 | -$497,000.00 | -$4.99M | -$914,000.00 |
| Net cash flow from investing | -$135.65M | $24.51M | $265.52M | -$64.58M | $389.41M |
| Net Cash Flow from Continuing Investing Activities | -$135.65M | $24.51M | $265.52M | -$64.58M | $389.41M |
| Net PPE Purchase and Sale | -$5.63M | -$6.26M | -$3.48M | -$32.56M | -$16.59M |
| Net Investment Purchase and Sale | -$130.02M | $30.77M | $284.00M | -$2.01M | $436.00M |
| Net Other Investing Changes | $0.00 | $0.00 | -$15.00M | -$30.00M | – |
| Financing Cash Flow | $23.64M | $27.18M | $29.51M | $954.07M | $33.86M |
| Net Cash Flow from Continuing Financing Activities | $23.64M | $27.18M | $29.51M | $954.07M | $33.86M |
| Net Issuance Payments Of Debt | -$843,000.00 | -$827,000.00 | -$799,000.00 | -$4.93M | -$776,000.00 |
| Net Common Stock Issuance | $0.00 | – | – | $823.28M | $0.00 |
| Proceeds from Stock Option Exercised | $24.48M | $28.01M | $30.31M | $135.72M | $34.64M |
| Ending Cash Balance | $396.56M | $544.77M | $582.19M | $510.45M | $510.45M |
| Net Change in Cash | -$148.47M | -$37.14M | $72.30M | -$45.52M | $175.67M |
| Beginning Cash Balance | $544.77M | $582.19M | $510.45M | $555.03M | $334.76M |
| Effect of Exchange Rate Changes | $269,000.00 | -$287,000.00 | -$553,000.00 | $931,000.00 | $7,000.00 |
| Free Cash Flow | -$42.09M | -$95.09M | -$226.22M | -$967.58M | -$264.19M |
No comments yet — be the first to weigh in on INSM.
Sign in to join the discussion.